DekaBank Deutsche Girozentrale’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-70,216
Closed -$632K – 1271
2023
Q1
$632K Buy
70,216
+1,293
+2% +$15.3K ﹤0.01% 967
2022
Q4
$829K Sell
68,923
-26,505
-28% -$330K ﹤0.01% 926
2022
Q3
$1.2M Buy
95,428
+8,802
+10% +$154K ﹤0.01% 831
2022
Q2
$1.71M Buy
86,626
+16,407
+23% +$388K 0.01% 755
2022
Q1
$1.89M Buy
70,219
+2,999
+4% +$79.9K ﹤0.01% 766
2021
Q4
$1.89M Buy
67,220
+9,521
+17% +$296K ﹤0.01% 788
2021
Q3
$1.86M Sell
57,699
-69
-0.1% -$2.31K 0.01% 737
2021
Q2
$2.02M Sell
57,768
-603
-1% -$19.9K 0.01% 720
2021
Q1
$1.67M Buy
58,371
+6,024
+12% +$185K 0.01% 755
2020
Q4
$1.63M Sell
52,347
-31,126
-37% -$950K 0.01% 724
2020
Q3
$2.19M Buy
83,473
+51,670
+162% +$1.31M 0.01% 578
2020
Q2
$657K Sell
31,803
-130,972
-80% -$2.89M ﹤0.01% 744
2020
Q1
$3.64M Sell
162,775
-54,499
-25% -$1.49M 0.03% 316
2019
Q4
$6.33M Buy
+217,274
New +$5.9M 0.04% 298
2019
Q1
– Sell
-81,500
Closed -$2.54M – 1217
2018
Q4
$2.54M Buy
+81,500
New +$2.67M 0.02% 486

Other funds holding ELAN

DekaBank Deutsche Girozentrale's ELAN Position: Q2 2023 in Review

DekaBank Deutsche Girozentrale sold out of Elanco Animal Health (ELAN) in Q2 2023, closing a stake of 70,216 shares — an estimated $632K sold.

DekaBank Deutsche Girozentrale first reported a position in ELAN in Q4 2018 and held it in 15 quarters. The position peaked at $6.33M in Q4 2019. 352 funds tracked by Wall St. Rank hold ELAN as of Q2 2023.

  • DekaBank Deutsche Girozentrale reported no remaining Elanco Animal Health position as of Q2 2023 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 70,216 Elanco Animal Health shares in Q2 2023, an estimated $632K.
  • DekaBank Deutsche Girozentrale first reported a position in Elanco Animal Health in Q4 2018 and held it in 15 quarters.
  • DekaBank Deutsche Girozentrale's Elanco Animal Health position peaked at $6.33M in Q4 2019.
  • 352 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2023, filed 25 Jul 2023.